OpusPoint Partners was co-founded in 2009 by Lindsay Rosenwald, M.D., and Michael Weiss. This revolutionary joint venture was to be one that assisted in putting a necessary focus on the growth of emerging biotechnology and life science companies. The promising studies and trials performed by these up and coming biotech firms are what potentially can stamp out life threatening illnesses around the world.
Rosenwald and Weiss recognized the need to support the efforts of these developing companies and through OpusPoint Partners they are able to make the ideal notion of a world with less disease a possibility.
Both men have an overwhelming passion for creating and buttressing biotechnology and life science studies, and each has done so for over 20 years respectively. Lindsey Rosenwald and Michael Weiss have both independently and jointly invested in the development of biotech companies, helping them grow with their expertise and finely tuned ethic compass. It is their desires to not only see these life science and biotech firms succeed but to do so justly without deception.
Lindsay Rosenwald brings his extraordinary knowledge of both finance and biotechnology into play with OpusPoint Partners. Dr. Rosenwald has accomplished much in both his academic life and professional career. He holds two degrees, a Bachelor of Science in Finance from Pennsylvania State University and a Doctor of Medicine from Temple University School of Medicine.
Beyond Rosenwald’s academic achievements, he is a successful entrepreneur in the biotechnology field. He has been the driving force behind nearly 50 biotech companies over the span of 20+ years. One of these successful ventures was Cougar Biotechnology Inc., which among its many intriguing studies and drug trials a notable drug that helped thwart the growth prostate cancer in the late stages was discovered. In 2009 Lindsay Rosenwald sold Cougar Biotechnology to Johnson & Johnson for roughly one billion dollars. It is around this time that Rosenwald and Weiss teamed up for a new endeavor together.
With Dr. Rosenwald’s track record it is safe to say that that he has a knack for creating biotech success. Over the last few years with OpusPoint Partners he has aided approximately 20 biotech companies expand their businesses and studies to an extent that would have not been fathomable without the positive backing from the co-founders of this remarkable biotechnology investing firm.
OpusPoint Partners through the assistance of Lindsay Rosenwald as well as other biotech and life science investors are trying to bring a change to the field of drug development by giving biotech companies a fighting chance to make a positive impact in the world of medicine. This desire to influence innovation is based on strong ethical standards and a shared belief that integrity and advance technological thinking is what makes a good biotech business thrive.
This biotechnology investing company doesn’t solely work on their own, OpusPiont Partners also works alongside other investors, researchers, and corporations to find and contribute to the development of biotechnology firms that have great aspirations and ideas but lack the financials and bureaucratic know how to achieve their scientific goals. Lindsay Rosenwald is there to act as a guiding force pathing the way for emergent biotech companies to make a splash in the discovery of life saving drugs.
Dr. Rosenwald has proven time and time again that he is more than adept at making and administrating appropriate investments that are beneficial all around the board. Prior to his time at his current position he managed the Aries Fund (1994 or 2007) and the Orion Fund (2002 to 2006), both of which have made substantial contributions to furthering the efforts of biotechnology and life science companies and their initiatives.
Investors can be sure that with Lindsay Rosenwald managing their investments their risks will be minimal. Rosenwald and Weiss specifically hand pick biotech companies that show not only promise of positive investment growth but also of potentially successful drug research and trials. OpusPoint Partners are committed to staying true to their integrity on both the financial and science areas. A motto of prevailing honesty and discretion is what keeps investors with this company.
OpusPoint Partners sets itself apart from the competition by way of Rosenwald and Weiss’ dedication to remain transparent with their investors and being unyielding in their expectations for ethical research and trials of potentially lifesaving medicine. This steadfastness combined with the immense competency both men bring to the company ensures that OpusPoint Partners will experience continued progression and be a part of necessary discoveries in the biotech industry.
In less than two years at OpusPoint Partners, Lindsay Rosenwald has assisted in financing and mentoring more than 20 biotech companies through his robust financing connections in the biotechnology and life science sectors. OpusPoint Partners still has much more to accomplish and it is obvious that this company is in for a steady run of growth in the years to come.
Lindsay Rosenwald activities outside of his career include being a member of the Board of Directors of the Republican Jewish Coalition.